相似文献
1
Response: Comment on "Significant decrease in plasma D-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism".
Clin Cardiol. 2022 Oct;45(10):976. doi: 10.1002/clc.23916. Epub 2022 Sep 8.
2
Comment on "significant decrease in plasma d-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism".
Clin Cardiol. 2022 Oct;45(10):975. doi: 10.1002/clc.23917. Epub 2022 Sep 8.
3
Significant decrease in plasmad-dimer levels and mean platelet volume after a 3-month treatment with rosuvastatin in patients with venous thromboembolism.
Clin Cardiol. 2022 Jul;45(7):717-722. doi: 10.1002/clc.23833. Epub 2022 Apr 28.
4
Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
Int J Gynecol Cancer. 2015 Jan;25(1):24-32. doi: 10.1097/IGC.0000000000000303.
5
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy.
AIDS Res Hum Retroviruses. 2017 Feb;33(2):126-132. doi: 10.1089/AID.2016.0134. Epub 2016 Oct 14.
6
[Clinical use of D-dimer testing in venous thromboembolism].
Rev Med Interne. 2016 May;37(5):303-6. doi: 10.1016/j.revmed.2015.06.009. Epub 2015 Jun 30.
7
New combinational assay using soluble fibrin and d-dimer determinations: a promising strategy for identifying patients with suspected venous thromboembolism.
PLoS One. 2014 Mar 24;9(3):e92379. doi: 10.1371/journal.pone.0092379. eCollection 2014.
8
Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients.
Oncol Res Treat. 2020;43(9):414-427. doi: 10.1159/000508271. Epub 2020 Jun 24.
9
Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):365-373. doi: 10.1161/ATVBAHA.116.308253. Epub 2016 Dec 29.
10
Fibrin-related markers for diagnosing acute-, subclinical-, and pre-venous thromboembolism in patients with major orthopedic surgery.
Int J Hematol. 2016 May;103(5):560-6. doi: 10.1007/s12185-016-1954-x. Epub 2016 Feb 12.
引用本文的文献
1
Can Rosuvastatin Reduce the Risk of Thrombosis in Patients with Hypercholesterolemia with its Effect on Coagulation Factors and Homocysteine Levels?
Cardiovasc Hematol Agents Med Chem. 2024;22(4):495-502. doi: 10.2174/0118715257279903231205110750.
本文引用的文献
1
Studies on Mean Platelet Volume (MPV) - New Editorial Policy.
Platelets. 2016 Nov;27(7):605-606. doi: 10.1080/09537104.2016.1225467. Epub 2016 Sep 9.
2
Were the measurements standardized sufficiently in published studies about mean platelet volume?
Blood Coagul Fibrinolysis. 2017 Apr;28(3):234-236. doi: 10.1097/MBC.0000000000000586.
3
Mean platelet volume measurement, EDTA or citrate?
Hematology. 2006 Oct;11(5):317-9. doi: 10.1080/10245330600954163.
Zotero 插件